Testing teicoplanin allergy with your own blood
Part of Immune system & allergy clinical trials.
This study tests a new way to check if you are allergic to the antibiotic teicoplanin using your own blood serum. It aims to help doctors know for sure if you had a severe allergic reaction during a past surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have had a severe allergic reaction (anaphylaxis) during anesthesia where teicoplanin was given.
- You must be able to temporarily stop medicines that can interfere with skin tests (like antihistamines or certain antipsychotics).
- You cannot be pregnant.
- You cannot have a blood-borne virus (like hepatitis B, C, or HIV).
- You cannot have a high baseline mast cell tryptase level that needs more investigation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests better ways to diagnose allergies to common cephalosporin antibiotics, like Keflex and Rocephin. By participating, you may learn if you are truly allergic to these medicines and if they are safe for you to take in the future.
This study is working to improve how doctors figure out if you are truly allergic to certain antibiotics (beta-lactams). It will test a new way to tell who is really allergic from who isn't, which could help avoid unnecessary restrictions on important medicines.
This study tests a new blood testing device on healthy adults to see if it works well and is easy to use. It may help improve how blood tests are done in the future.
This trial is testing a new way to diagnose allergies to amoxicillin, a common antibiotic. It may help people who think they might be allergic to amoxicillin find out for sure.
This study checks whether a new blood test can measure allergy-related immune signals (IgE) in people with known or suspected allergies. If it works well, it could help doctors diagnose and track IgE allergies more easily.
This study looks at how the antibiotic teicoplanin is processed in the body of patients with blood cancers or critical illness. The goal is to find the right dose for each person to better treat infections.
Hear when a new Drug Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.